Skip to main content
SpringerLink
Log in
Book cover

Renal Cancer pp 361–386Cite as

Postoperative Surveillance Protocols for Renal Cell Carcinoma

  • Chapter
  • First Online:

  • 719 Accesses

Abstract

Patients with renal cell carcinoma (RCC) are at risk of recurrence even after definitive surgical extirpation. Without prompt identification and treatment of recurrent disease, prognosis is poor. Literature suggests that early intervention in the form of metastasectomy and/or targeted therapy can lead to prolonged survival in those who develop recurrent or metastatic RCC. Therefore, surveillance in the postoperative setting is of paramount importance.

Currently, there is no single consensus on the optimal surveillance strategy following radical or partial nephrectomy or ablative therapies used to treat RCC. The purpose of this chapter is to provide a comprehensive review of the existing data on postoperative surveillance strategies and how prognostic factors and patterns of recurrence have contributed to the establishment of such protocols.

The specific components of surveillance are described, and several evidence-based recommendations are reviewed, including the most recent AUA guidelines, the 2018 National Comprehensive Cancer Network (NCCN) guidelines, and a surveillance algorithm based on the UCLA-Integrated Scoring System (UISS). Briefly, new frontiers in surveillance are also discussed, such as the use of PET imaging and the incorporation of molecular biomarkers into existing surveillance models.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Siegel R, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67:7–30.

    PubMed  Google Scholar 

  2. Janzen NK, Kim HL, Figlin RA, Belldegrun AS. Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease. Urol Clin North Am. 2003;30(4):843–52.

    Article  PubMed  Google Scholar 

  3. Rabinovitch RA, Zelefsky MJ, Gaynor JJ, Fuks Z. Patterns of failure following surgical resection of renal cell carcinoma: implications for adjuvant local and systemic therapy. J Clin Oncol. 1994;12(1):206–12.

    Article  CAS  PubMed  Google Scholar 

  4. Ramon J, Goldwasser B, Raviv G, Jonas P, Many M. Long-term results of simple and radical nephrectomy for renal cell carcinoma. Cancer. 1991;67(10):2506–11.

    Article  CAS  PubMed  Google Scholar 

  5. Maldazys JD, deKernion JB. Prognostic factors in metastatic renal carcinoma. J Urol. 1986;136(2):376–9.

    Article  CAS  PubMed  Google Scholar 

  6. Negrier S, Escudier B, Gomez F, Douillard JY, Ravaud A, Chevreau C, Bucion M, Perol D, Lasset C. Prognostic factors of survival and rapid progression in 782 patients with metastatic renal carcinomas treated by cytokines: a report from the Groupe Francais d’ Immunotherapie. Ann Oncol. 2002;13(9):1460–8.

    Article  CAS  PubMed  Google Scholar 

  7. Motzer RJ, Rini BI, Bukowski RM, Curti BD, George DJ, Hudes GR, Redman BG, Margolin KA, Merchan JR, Wilding G, Ginsberg MS, Bacik J, Kim ST, Baum CM, Michaelson MD. Sunitinib in patients with metastatic renal cell carcinoma. JAMA. 2006;295(21):2516–24.

    Article  CAS  PubMed  Google Scholar 

  8. Hofmann HS, Neef H, Krohe K, Andreev P, Silber RE. Prognostic factors and survival after pulmonary resection of metastatic renal cell carcinoma. Eur Urol. 2005;48(1):77–81.

    Article  PubMed  Google Scholar 

  9. Baloch KG, Grimer RJ, Carter SR, Tillman RM. Radical surgery for the solitary bony metastasis from renal cell carcinoma. J Bone Joint Surg Br. 2000;82(1):62–7.

    Article  CAS  PubMed  Google Scholar 

  10. Sandhu SS, Symes A, A’Hern R, Sohaib SA, Eisen T, Gore M, Christmas TJ. Surgical excision of isolated renal-bed recurrence after radical nephrectomy for renal cell carcinoma. BJU Int. 2005;95(4):522–5.

    Article  PubMed  Google Scholar 

  11. Chawla SN, Crispen PL, Hanlon AL, Greenberg RE, Chen DY, Uzzo RG. The natural history of observed enhancing renal masses: metaanalysis and review of the world literature. J Urol. 2006;175(2):425–31.

    Article  PubMed  Google Scholar 

  12. Johnsen JA, Hellsten S. Lymphatogenous spread of renal cell carcinoma: an autopsy study. J Urol. 1997;157(2):450–3.

    Article  CAS  PubMed  Google Scholar 

  13. Hafez KS, Novick AC, Campbell SC. Patterns of recurrence and guidelines for follow-up after nephron-sparing surgery for sporadic renal cell carcinoma. J Urol. 1997;157(6):2067–70.

    Article  CAS  PubMed  Google Scholar 

  14. Levy DA, Slaton JW, Swanson DA, Dinney CP. Stage specific guidelines for surveillance after radical nephrectomy for local renal cell carcinoma. J Urol. 1998;159(4):1163–7.

    Article  CAS  PubMed  Google Scholar 

  15. Ljungberg B, Alamdari FI, Rasmuson T, Roos G. Follow-up guidelines for nonmetastatic renal cell carcinoma based on the occurrence of metastases after radical nephrectomy. BJU Int. 1999;84(4):405–11.

    Article  CAS  PubMed  Google Scholar 

  16. Sandock DS, Seftel AD, Resnick MI. A new protocol for the followup of renal cell carcinoma based on pathological stage. J Urol. 1995;154(1):28–31.

    Article  CAS  PubMed  Google Scholar 

  17. Stephenson AJ, Chetner MP, Rourke K, Gleave ME, Signaevsky M, Palmer B, Kuan J, Brock GB, Tanguay S. Guidelines for the surveillance of localized renal cell carcinoma based on the patterns of relapse after nephrectomy. J Urol. 2004;172(1):58–62.

    Article  PubMed  Google Scholar 

  18. Lam JS, Leppert JT, Figlin RA, Belldegrun AS. Surveillance following radical or partial nephrectomy for renal cell carcinoma. Curr Urol Rep. 2005;6(1):7–18.

    Article  PubMed  Google Scholar 

  19. Chin AI, Lam JS, Figlin RA, Belldegrun AS. Surveillance strategies for renal cell carcinoma patients following nephrectomy. Rev Urol. 2006;8(1):1–7.

    PubMed  PubMed Central  Google Scholar 

  20. Skolarikos A, Alivizatos G, Laguna P, de la Rosette J. A review on follow-up strategies for renal cell carcinoma after nephrectomy. Eur Urol. 2007;51(6):1490–500.

    Article  PubMed  Google Scholar 

  21. Shvarts O, Lam JS, Kim HL, Han KR, Figlin R, Belldegrun A. Eastern cooperative oncology group performance status predicts bone metastasis in patients presenting with renal cell carcinoma: implication for preoperative bone scans. J Urol. 2004;172(3):867–70.

    Article  PubMed  Google Scholar 

  22. Lam JS, Shvarts O, Leppert JT, Pantuck AJ, Figlin RA, Belldegrun AS. Postoperative surveillance protocol for patients with localized and locally advanced renal cell carcinoma based on a validated prognostic nomogram and risk group stratification system. J Urol. 2005;174(2):466–72.

    Article  PubMed  Google Scholar 

  23. Breda A, Konijeti R, Lam JS. Patterns of recurrence and surveillance strategies for renal cell carcinoma following surgical resection. Expert Rev Anticancer Ther. 2007;7(6):847–62.

    Article  PubMed  Google Scholar 

  24. Itano NB, Blute ML, Spotts B, Zincke H. Outcome of isolated renal cell carcinoma fossa recurrence after nephrectomy. J Urol. 2000;164(2):322–5.

    Article  CAS  PubMed  Google Scholar 

  25. Psutka SP, Heidenreich M, Boorjian SA, Bailey GC, Cheville JC, Stewart-Merrill SB, Lohse CM, Atwell TD, Costello BA, Leibovich BC, Thompson RH. Renal fossa recurrence after nephrectomy for renal cell carcinoma: prognostic features and oncological outcomes. BJU Int. 2017;119:116–27.

    Article  PubMed  Google Scholar 

  26. Margulis V, McDonald M, Tamboli P, Swanson DA, Wood CG. Predictors of oncological outcome after resection of locally recurrent renal cell carcinoma. J Urol. 2009;181(5):2044–51.

    Article  PubMed  Google Scholar 

  27. Fergany AF, Hafez KS, Novick AC. Long-term results of nephron-sparing surgery for localized renal cell carcinoma: 10-year followup. J Urol. 2000;163(2):442–5.

    Article  CAS  PubMed  Google Scholar 

  28. Campbell SC, Novick AC, Belldegrun AS, Blute ML, Chow GK, Derweesh IH, Faraday MM, Kaouk JH, Leveillee RJ, Matin SF, Russo P, Uzzo RG. Guideline for management of the clinical T1 renal mass. J Urol. 2009;182(4):1271–9.

    Article  PubMed  Google Scholar 

  29. Leibovich BC, Blute M, Cheville JC, Lohse CM, Weaver AL, Zincke H. Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy. J Urol. 2004;171(3):1066–70.

    Article  PubMed  Google Scholar 

  30. Yossepowitch O, Thompson RH, Leibovich BC, Eggener SE, Pettus JA, Kwon ED, Herr HW, Blute ML, Russo P. Positive surgical margins at partial nephrectomy: predictors and oncological outcomes. J Urol. 2008;179:2158–63.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Bensalah K, Pantuck AJ, Rioux-Leclercq N, Thuret R, Montorsi F, Karakiewicz PI, Mottet N, Zini L, Bertini R, Salomon L, Villers A, Soulie M, Bellec L, Rischmann P, De La Taille A, Avakian R, Crepel M, Ferriere JM, Bernhard JC, Dujardin T, Pouliot F, Rigaud J, Pfister C, Albouy B, Guy L, Joniau S, Van Poppel H, Lebret T, Culty T, Saint F, Zisman A, Raz O, Lang H, Spie R, Wille A, Roigas J, Aguilera A, Rambeaud B, Pineiro LM, Nativ O, Farfara R, Richard F, Roupret M, Doehn C, Bastian PJ, Muller SC, Tostain J, Belldegrun AS, Patard JJ. Positive surgical margin appears to have negligible impact on survival of renal cell carcinoma treated by nephron-sparing surgery. Eur Urol. 2010;57:466–73.

    Article  PubMed  Google Scholar 

  32. Wood EL, Adibi M, Qiao W, Brandt J, Zhang M, Tamboli P, Matin SF, Wood CG, Karam JK. Local tumor bed recurrence following partial nephrectomy in patients with small renal masses. J Urol. 2018;199(2):393–400.

    Article  PubMed  Google Scholar 

  33. Desai MM, Gill IS. Current status of cryoablation and radiofrequency ablation in the mangagement of renal tumors. Curr Opin Urol. 2002;12(5):387–93.

    Article  PubMed  Google Scholar 

  34. Karam JA, Wood CG. The role of surgery in advanced renal cell carcinoma: cytoreductive nephrectomy and metastasectomy. Hematol Oncol Clin North Am. 2011;25(4):753–64.

    Article  PubMed  Google Scholar 

  35. Alt AL, Boorjian SA, Lohse CM, Costello BA, Leibovich BC, Blute ML. Survival after complete surgical resection of multiple metastases from renal cell carcinoma. Cancer. 2011;117(13):2873–82.

    Article  PubMed  Google Scholar 

  36. Motzer RJ, Bacik J, Murphy BA, Russo P, Mazumdar M. Interferon-alfa as a comparative treatment for clincal trials of new therapies against advanced renal cell carcinoma. J Clin Oncol. 2002;20(1):289–96.

    Article  CAS  PubMed  Google Scholar 

  37. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, Hogg RJ, Perrone RD, Lau J, Eknoyan G, National Kidney Foundation. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med. 2003;139(2):137–47.

    Article  PubMed  Google Scholar 

  38. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351(13):1296–305.

    Article  CAS  PubMed  Google Scholar 

  39. Chae EJ, Kim JK, Kim SH, Bae SJ, Cho KS. Renal cell carcinoma: analysis of postoperative recurrence patterns. Radiology. 2005;234:189–96.

    Article  PubMed  Google Scholar 

  40. Bianchi M, Becker A, Hansen J, Trinh Q, Tian Z, Abdollah F, Briganti A, Shariat SF, Perrotte P, Montorsi F, Karakiewicz PI, Sun M. Conditional survival after nephrectomy for renal cell carcinoma (RCC): changes in future survival probability over time. BJU Int. 2013;111(8):E283–9.

    Article  PubMed  Google Scholar 

  41. Kattan MW, Reuter V, Motzer R, Katz J, Russo P. A postoperative prognostic nomogram for renal cell carcinoma. J Urol. 2001;166(1):63–7.

    Article  CAS  PubMed  Google Scholar 

  42. Rini BI, Vogelzang NJ. Prognostic factors in renal carcinoma. Semin Oncol. 2000;27(2):213–20.

    CAS  PubMed  Google Scholar 

  43. Delahunt B, Kittelson JM, McCredie MR, Reeve AE, Stewart JH, Bilous AM. Prognostic importance of tumor size for localized conventional (clear cell) renal cell carcinoma: assessment of TNM T1 and T2 tumor categories and comparison with other prognostic parameters. Cancer. 2002;94(3):658–64.

    Article  PubMed  Google Scholar 

  44. Cheville JC, Blute ML, Zincke H, Lohse CM, Weaver AL. Stage pT1 conventional (clear cell) renal cell carcinoma: pathological features associated with cancer specific survival. J Urol. 2001;166(2):453–6.

    Article  CAS  PubMed  Google Scholar 

  45. Giuliani L, Giberti C, Martorana G, Rovida S. Radical extensive surgery for renal cell carcinoma: long-term results and prognostic factors. J Urol. 1990;143(3):468–73.

    Article  CAS  PubMed  Google Scholar 

  46. Sorbellini M, Kattan MW, Snyder ME, Reuter V, Motzer R, Goetzi M, McKiernan J, Russo P. A postoperative prognostic nomogram predicting recurrence for patients with conventional clear cell renal cell carcinoma. J Urol. 2005;173(1):48–51.

    Article  PubMed  Google Scholar 

  47. Delahunt B, Eble J, McCredie MR, Bethwaite PB, Stewart JH, Bilous AM. Morphologic typing of papillary renal cell carcinoma: comparison of growth kinetics and patient survival in 66 cases. Hum Pathol. 2001;32(6):590–5.

    Article  CAS  PubMed  Google Scholar 

  48. Amin MB, Amin MB, Tamboli P, Javidan J, Stricker H, de-Peralta Venturina M, Deshpande A, Menon M. Prognostic impact of histologic subtyping of adult renal epithelial neoplasms: an experience of 405 cases. Am J Surg Pathol. 2002;26(3):281–91.

    Article  PubMed  Google Scholar 

  49. Patard JJ, Leray E, Rioux-Leclercq N, Cindolo L, Ficarra V, Zisman A, De La Taille A, Tostain J, Artibani W, Abbou CC, Lobel B, Guille F, Chopin DK, Mulders PF, Wood CG, Swanson DA, Figlin RA, Belldegrun AS, Pantuck AJ. Prognostic value of histologic subtypes in renal cell carcinoma: a multicenter experience. J Clin Oncol. 2005;23(12):2763–71.

    Article  PubMed  Google Scholar 

  50. Abel EJ, Culp SH, Meissner M, Matin SF, Tamboli P, Wood CG. Identifying the risk of disease progression after surgery for localized renal cell carcinoma. BJU Int. 2010;106(9):1277–83.

    Article  PubMed  Google Scholar 

  51. Sella A, Logothetis CJ, Ro JY, Swanson DA, Samuels ML. Sarcomatoid renal cell carcinoma. A treatable entity. Cancer. 1987;60(6):1313–8.

    Article  CAS  PubMed  Google Scholar 

  52. Narayan V, Puligandla M, Haas NB, Subramanian P, DiPaola RS, Uzzo R. Patterns of relapse and implications for post-nephrectomy surveillance for patients with high-risk non-clear cell renal cell carcinoma: subgroup analysis of the phase 3 ECOG-ACRIN E2805 trial. J Urol. 2019;201(1):62–8.

    Article  PubMed  PubMed Central  Google Scholar 

  53. Frank I, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H. An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score. J Urol. 2002;168(6):2395–400.

    Article  PubMed  Google Scholar 

  54. Raj GV, Thompson RH, Leibovich BC, Blute ML, Russo P, Kattan MW. Preoperative nomogram predicting 12-year probability of metastatic renal cancer. J Urol. 2008;179(6):2146–51.

    Article  PubMed  PubMed Central  Google Scholar 

  55. Zisman A, Pantuck AJ, Dorey F, Said JW, Shvarts O, Quintana D, Gitlitz BJ, deKernion JB, Figlin RA, Belldegrun AS. Improved prognostication of RCC using an integrated staging system (UISS). J Clin Oncol. 2001;19(6):1649–57.

    Article  CAS  PubMed  Google Scholar 

  56. Mickisch G, Carballido J, Hellsten S, Schulze H, Mensink H. Guidelines on renal cell cancer. Eur Urol. 2001;40:252–5.

    Article  CAS  PubMed  Google Scholar 

  57. Stephenson AJ, Chetner MP, Rourke K, Gleave ME, Signaevsky M, Palmer B, et al. Guidelines for the surveillance of localized renal cell carcinoma based on the patterns of relapse after nephrectomy. J Urol [Research Support, Non-U.S. Gov’t Research Support, U.S. Gov’t, P.H.S.]. 2004;172(1):58–62.

    Google Scholar 

  58. Novick AC, Derweesh I. Open partial nephrectomy for renal tumours: current status. BJU Int. 2005;95(Suppl 2):35–40.

    Article  PubMed  Google Scholar 

  59. Kassouf W, Siemens R, Morash C, Lacombe L, Jewett M, Goldenberg L, Chin J, Chetner M, Wood CG, Tanguay S, Aprikian AG. Follow-up guidelines after radical or partial nephrectomy for localized and locally advanced renal cell carcinoma. Can Urol Assoc J. 2009;3(1):73–6.

    Article  PubMed  PubMed Central  Google Scholar 

  60. Montie JE. Follow-up after partial or total nephrectomy for renal cell carcinoma. Urol Clin North Am. 1994;21(4):589–92.

    CAS  PubMed  Google Scholar 

  61. Saidi JA, Newhouse JH, Sawczuk IS. Radiologic follow-up of patients with T1-3a,b,c or T4N+M0 renal cell carcinoma after radical nephrectomy. Urology [Clinical Trial Randomized Controlled Trial Research Support, Non-U.S. Gov’t]. 1998;52(6):1000–3.

    CAS  Google Scholar 

  62. Frank I, Blute ML, Cheville JC, Lohse CM, Weaver AL, Leibovich BC, et al. A multifactorial postoperative surveillance model for patients with surgically treated clear cell renal cell carcinoma. J Urol. 2003;170(6 Pt 1):2225–32.

    Article  PubMed  Google Scholar 

  63. Antonelli A, Cozzoli A, Zani D, Zanotelli T, Nicolai M, Cunico SC, Simeone C. The follow-up management of non-metastatic renal cell carcinoma: definition of a surveillance protocol. BJU Int. 2006;99(2):296–300.

    Article  Google Scholar 

  64. Patard JJ, Kim HL, Lam JS, Dorey FJ, Pantuck AJ, Zisman A, Ficarra V, Han KR, Cindolo L, De La Taille A, Tostain J, Artibani W, Dinney CP, Wood CG, Swanson DA, Abbou CC, Lobel B, Mulders PF, Chopin DK, Figlin RA, Belldegrun AS. Use of the University of California Los Angeles integrated staging system to predict survival in renal cell carcinoma: an international multicenter study. J Clin Oncol. 2004;22(16):3316–22.

    Article  PubMed  Google Scholar 

  65. Capogrosso P, Larcher A, Sjoberg DD, Vertosick EA, Cianflone F, Dell’Oglio P, Carenzi C, Salonia A, Vickers AJ, Montorsi F, Bertini R, Capitanio U. Risk based surveillance after surgical treatment of renal cell carcinoma. J Urol. 2018;200(1):61–7.

    Article  PubMed  PubMed Central  Google Scholar 

  66. Siddiqui SA, Frank I, Cheville JC, Lohse CM, Leibovich BC, Blute ML. Postoperative surveillance for renal cell carcinoma: a multifactorial histological subtype specific protocol. BJU Int. 2009;104(6):778–85.

    Article  PubMed  Google Scholar 

  67. Stewart-Merrill SB, Thompson RH, Psutka SP, Cheville JC, Lohse CM, Boorjian SA, Leibovich BC. Evaluation of the National Comprehensive Cancer Network and American Urological Association renal cell carcinoma surveillance guidelines. J Clin Oncol. 2014;32(36):4059–65.

    Article  Google Scholar 

  68. Stewart-Merrill SB, Thompson RH, Boorjian SA, Psutka SP, Lohse CM, Cheville JC, Leibovich BC, Frank I. Oncologic surveillance after surgical resection for renal cell carcinoma: a novel risk-based approach. J Clin Oncol. 2015;33(35):4151–7.

    Article  PubMed  Google Scholar 

  69. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Kidney Cancer (V.4.2018) © 2018 National Comprehensive Cancer Network, Inc. Available at: NCCN.org. Accessed 21 Aug 2018. To view the most recent and complete version of the NCCN Guidelines®, go on-line to NCCN.org.

  70. AUA Clincal Practice Guidelines: follow-up for clinically localized renal neoplasms. 2013. Available at auanet.org. Accessed 21 Aug 2018.

  71. Steinbach F, Novick AC, Zincke H, Miller DP, Williams RD, Lund G, Skinner DG, Esrig D, Richie JP, Dekernion JB, et al. Treatment of renal cell carcinoma in von Hippel-Lindau disease: a multicenter study. J Urol. 1995;153(6):1812–6.

    Article  CAS  PubMed  Google Scholar 

  72. Duffey BG, Choyke PL, Glenn G, Grubb RL, Venzon D, Linehan WM, et al. The relationship between renal tumor size and metastases in patients with von Hippel-Lindau disease. J Urol. 2004;172(1):63–5.

    Article  PubMed  Google Scholar 

  73. Meister M, Choyke P, Anderson C, Patel U. Radiological evaluation, management, and surveillance of renal masses in von hippel-lindau disease. Clin Radiol. 2009;64(6):589–600.

    Article  CAS  PubMed  Google Scholar 

  74. Lotfi MA, McCue P, Gomella LG. Laparoscopic interstitial contact laser ablation of renal lesions: an experimental model. J Endourol. 1994;8:153–6.

    Article  CAS  PubMed  Google Scholar 

  75. Yoshimura K, Okubo K, Ichioka K, Terada N, Matsuta Y, Arai Y. Laparoscopic partial nephrectomy with a microwave tissue coagulator for small renal tumor. J Urol. 2001;165:1893–6.

    Article  CAS  PubMed  Google Scholar 

  76. Vallancien G, Chartier-Kastler E, Chopin D, Veillon B, Brisset JM, Andre-Bougaran J. Focussed extracorporeal pyrotherapy: experimental results. Eur Urol. 1991;20:211–9.

    Article  CAS  PubMed  Google Scholar 

  77. Watkin NA, Morris SB, Rivens IH, ter Haar GR. High-intensity focused ultrasound ablation of the kidney in a large animal model. J Endourol. 1997;11:191–6.

    Article  CAS  PubMed  Google Scholar 

  78. Klatte T, Mauermann J, Heinz-Peer G, Waldert M, Weibi P, Klingler HC, Remzi M. Perioperative, oncologic, and functional outcomes of laparoscopic renal cryoablation and open parital nephrectomy: a matched pair analysis. J Endourol. 2011;25(6):991–7.

    Article  PubMed  Google Scholar 

  79. Guazzoni G, Cestari A, Buffi N, Lughezzani G, Nava L, Cardone G, Balconi G, Lazzeri M, Montorsi F, Rigatti P. Oncologic results of laparoscopic renal cryoablation for clinical T1a tumors: 8 years of experience in a single institution. Urology. 2010;76(3):624–9.

    Article  PubMed  Google Scholar 

  80. Aron M, Kamoi K, Remer E, Berger A, Desai M, Gill IS. Laparoscopic renal cryoablation: 8-year, single surgeon outcomes. J Urol. 2010;183(3):889–95.

    Article  PubMed  Google Scholar 

  81. El Dib R, Touma NJ, Kapoor A. Cryoablation vs radiofrequency ablation for the treatment of renal cell carcinoma: a meta-analysis of case series studies. BJU Int. 2012;110(4):510–6.

    Article  PubMed  Google Scholar 

  82. Tracy CR, Raman JD, Donnally C, Trimmer CK, Cadeddu JA. Durable oncologic outcomes after radiofrequency ablation: experience from treating 243 small renal masses over 7.5 years. Cancer. 2010;116(13):3135–42.

    Article  PubMed  Google Scholar 

  83. Matsumoto ED, Watumull L, Johnson DB, Ogan K, Taylor GD, Joseph S, Cadeddu JA. The radiographic evolution of radio frequency ablated renal tumors. J Urol. 2004;172(1):45–8.

    Article  PubMed  Google Scholar 

  84. Kawamoto S, Permpongkosol S, Bluemke DA, Fishman EK, Solomon SB. Sequential changes after radiofrequency ablation and cryoablation of renal neoplasms: role of CT and MR imaging. Radiographics. 2007;27(2):343–55.

    Article  PubMed  Google Scholar 

  85. Svatek RS, Sims R, Anderson JK, Abdel-Aziz K, Cadeddu JA. Magnetic resonance imaging characteristics of renal tumors after radiofrequency ablation. Urology. 2006;67(3):508–12.

    Article  PubMed  Google Scholar 

  86. Rendon RA, Kachura JR, Sweet JM, Gertner MR, Sherar MD, Robinette M, Tshlias J, Trachtenberg J, Sampson H, Jewett MA. The uncertainty of radio frequency treatment of renal cell carcinoma: findings at immediate and delayed nephrectomy. J Urol. 2002;167(4):1587–92.

    Article  PubMed  Google Scholar 

  87. Weight CJ, Kaouk JH, Hegarty NJ, Remer EM, O’Malley CM, Lane BR, Gill IS, Novick AC. Correlation of radiographic imaging and histopathology following cryoablation and radio frequency ablation for renal tumors. J Urol. 2008;179(4):1277–81.

    Article  PubMed  Google Scholar 

  88. Cadeddu JA. Correlation of radiographic imaging and histopathology following cryoablation and radio frequency ablation for renal tumors – Editorial Comment. J Urol. 2008;179:1281–2.

    Article  Google Scholar 

  89. Campbell SC, Krishnamurthi V, Chow G, Hale J, Myles J, Novick AC. Renal cryosurgery: experimental evaluation of treatment parameters. Urology. 1998;52(1):33–4.

    Article  Google Scholar 

  90. Rukstalis DB, Khorsandi M, Garcia FU, Hoenig DM, Cohen JK. Clinical experience with open renal cryoablation. Urology. 2001;172:1267–70.

    Google Scholar 

  91. Gill IS, Remer EM, Hasan WA, Strzempkowski B, Spaliviero M, Steinberg AP, Kaouk JH, Desai MM, Novick AC. Renal cryoablation: outcome at 3 years. J Urol. 2005;173(6):1903–7.

    Article  PubMed  Google Scholar 

  92. Beemster P, Phoa S, Wijkstra H, de la Rosette J, Laguna P. Follow-up of renal masses after cryosurgery using computed tomography; enhancement patterns and cryolesion size. BJU Int. 2008;101(10):1237–42.

    Article  PubMed  Google Scholar 

  93. Matin SF, Ahrar K, Cadeddu JA, Gervais DA, McGovern FJ, Zagoria RA, Uzzo RG, Haaga J, Resnick MI, Kaouk J, Gill IS. Residual and recurrent disease following renal energy ablative therapy: a multi-institutional study. J Urol. 2006;176(5):1973–7.

    Article  PubMed  Google Scholar 

  94. Crispen PL, Boorjian SA, Lohse CM, Leibovich BC, Kwon ED. Predicting disease progression after nephrectomy for localized renal cell carcinoma: the utility of prognostic models and molecular biomarkers. Cancer. 2008;113(3):450–60.

    Article  PubMed  Google Scholar 

  95. Nogueira M, Kim HL. Molecular markers for predicting prognosis of renal cell carcinoma. Urol Oncol. 2008;26(2):113–24.

    Article  CAS  PubMed  Google Scholar 

  96. Johnson TV, Abbasi A, Owen-Smith A, Young AN, Kucuk O, Harris WB, et al. Postoperative better than preoperative C-reactive protein at predicting outcome after potentially curative nephrectomy for renal cell carcinoma. Urology. 2010;76(3):766.e1–5.

    Article  CAS  Google Scholar 

  97. Abel JE, Bauman TM, Weiker M, Shi F, Downs TM, Jarrard DF, Huang W. Analysis and validation of tissue biomarkers for renal cell carcinoma using automated high-throughput evaluation of protein expression. Hum Pathol. 2014;45(5):1092–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  98. Brenner DJ, Hall EJ. Computed tomography--an increasing source of radiation exposure. N Engl J Med. 2007;357(22):2277–84.

    Article  CAS  PubMed  Google Scholar 

  99. Smith-Bindman R. Is computed tomography safe? N Engl J Med. 2010;363(1):1–4.

    Article  CAS  PubMed  Google Scholar 

  100. Society RR. Radiation exposures in medicine: biological and public health significance american statistical association conference on radiation and health. Annapolis, Maryland, June 13-16, 2010. Radiat Res. 2010;175(1):131–42.

    Google Scholar 

  101. Kang DE, White RL Jr, Zuger JH, Sasser HC, Teigland CM. Clinical use of fluorodeoxyglucose F 18 positron emission tomography for detection of renal cell carcinoma. J Urol. 2004;171(5):1806–9.

    Article  PubMed  Google Scholar 

  102. Janzen NK, Laifer-Narin S, Han KR, Seltzer M, Thomas MA, Pantuck AJ, Belldegrun AS. Emerging technologies in uroradiologic imaging. Urol Oncol. 2003;21(5):317–26.

    Article  PubMed  Google Scholar 

  103. Kocher F, Grimmel S, Hautman R, et al. Preoperative lymph node staging in patients with kidney and urinary bladder neoplasm. J Nucl Med. 1994;35(suppl):233P.

    Google Scholar 

  104. Nakatani K, Nakamoto Y, Saga T, Higashi T, Togashi K. The potential clinical value of FDG-PET for recurrent renal cell carcinoma. Eur J Radiol. 2011;79(1):29–35.

    Article  PubMed  Google Scholar 

  105. Elahmadawy MA, Saied Elazab MS, Ahmed S, Salama M. Diagnostic value of F-18 FDG PET/CT for local and distant disease relapse surveillance in surgically treated RCC patients: can it aid in establishing consensus follow up strategy? Nucl Med Rev Cent East Eur. 2018;21(2):85–91.

    Article  PubMed  Google Scholar 

  106. Dion M, Martínez CH, Williams AK, Chalasani V, Nott L, Pautler SE. Cost analysis of two follow-up strategies for localized kidney cancer: a Canadian cohort comparison. Can Urol Assoc J. 2010;4(5):322–6.

    Article  PubMed  PubMed Central  Google Scholar 

  107. Lobo JM, Nelson M, Nandanan N, Krupski TL. Comparison of renal cell carcinoma surveillance guidelines: competing trade-offs. J Urol. 2016;195(6):1664–70.

    Article  PubMed  Google Scholar 

  108. Dabestani S, Beisland C, Stewart GD, Bensalah K, Gudmundsson E, Lam TB, Gietzmann W, Zakikhani P, Marconi L, Fernandéz-Pello S, Monagas S, Williams SP, Torbrand C, Powles T, Van Werkhoven E, Meijer R, Volpe A, Staehler M, Ljungberg B, Bex A. Long-term outcomes of follow-up for initially localised clear cell renal cell carcinoma: RECUR Database Analysis. Eur Urol Focus. 2018; https://doi.org/10.1016/j.euf.2018.02.010.

  109. Dabestani S, Beisland C, Stewart GD, Bensalah K, Gudmundsson E, Lam TB, Gietzmann W, Zakikhani P, Marconi L, Fernandéz-Pello S, Monagas S, Williams SP, Torbrand C, Powles T, Van Werkhoven E, Meijer R, Volpe A, Staehler M, Ljungberg B, Bex A. Intensive imaging-based follow-up of surgically treated localised renal cell carcinoma does not improve post-recurrence survival: results from a European Multicentre Database (RECUR). Eur Urol. 2019;75(2):261–4.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Kaiser Permanente South Sacramento, Sacramento, CA, USA

    Megan M. Merrill

  2. Urology and Translational Molecular Pathology, MD Anderson Cancer Center, Houston, TX, USA

    Jose A. Karam

Authors
  1. Megan M. Merrill
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jose A. Karam
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jose A. Karam .

Editor information

Editors and Affiliations

  1. Professor of Urology, Tufts University School of Medicine, Boston, MA, USA

    John A. Libertino

  2. Associate Professor of Urology, Tufts University School of Medicine, Boston, MA, USA

    Jason R. Gee

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Merrill, M.M., Karam, J.A. (2020). Postoperative Surveillance Protocols for Renal Cell Carcinoma. In: Libertino, J., Gee, J. (eds) Renal Cancer. Springer, Cham. https://doi.org/10.1007/978-3-030-24378-4_21

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-24378-4_21

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-24377-7

  • Online ISBN: 978-3-030-24378-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation